Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 14/20 | 0.63 |
| ▸ | CA2 | P00918 | 14/20 | 0.63 |
| ▸ | CA9 | Q16790 | 14/20 | 0.63 |
| ▸ | CA12 | O43570 | 6/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.60 |
| ▸ | CA7 | P43166 | 2/20 | 0.60 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.53 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.53 |
| ▸ | GJA1 | P17302 | 1/20 | 0.52 |
| ▸ | GJB2 | P29033 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15314740 | 1.00 | CA1 (0.63) | CA1CA2CA9CA12CA14 | |
| SCHEMBL17342553 | 0.91 | CA1 (0.64) | CA1CA2CA9CA12CA14 | |
| SCHEMBL15314737 | 0.91 | CA1 (0.64) | CA1CA2CA9CA12CA14 | |
| SCHEMBL17340989 | 0.90 | GJA1 (0.49) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19961993 | 0.86 | CA1 (0.54) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19961511 | 0.86 | CA1 (0.57) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19962810 | 0.86 | CA1 (0.56) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19961504 | 0.86 | CA1 (0.56) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13271743 | 0.84 | CA1 (0.52) | CA1CA2CA9CA12CA14 | |
| SCHEMBL12608907 | 0.83 | CA9 (0.76) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371351-B2 | Glycomimetics as Pseudomonas aeruginosa lectin inhibitors | Universität Konstanz (DE) | 2016-06-21 | — | — | US | disclosed |
| US-20150361122-A1 | Glycomimetics As Pseudomonas Aeruginosa Lectin Inhibitors | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361122-A1 | Glycomimetics As Pseudomonas Aeruginosa Lectin Inhibitors | FUCA1, ALG1, MUC1 | CA1 4638/4885CA2 3949/4885CA9 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.